Journal article
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation
Abstract
Importance: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Observational studies report that β-blocker use may be associated with reduced risk of COPD exacerbations. However, a recent trial reported that metoprolol did not reduce COPD exacerbations and increased COPD exacerbations requiring hospital admission.
Objective: To test whether bisoprolol decreased COPD exacerbations in people with …
Authors
Devereux G; Cotton S; Nath M; McMeekin N; Campbell K; Chaudhuri R; Choudhury G; De Soyza A; Fielding S; Gompertz S
Journal
JAMA, Vol. 332, No. 6, pp. 462–470
Publisher
American Medical Association (AMA)
Publication Date
August 13, 2024
DOI
10.1001/jama.2024.8771
ISSN
0098-7484